共 50 条
- [42] Drug-coated vs uncoated balloon angioplasty in the treatment of femoropopliteal arterial lesions EGYPTIAN JOURNAL OF SURGERY, 2020, 39 (01): : 252 - 260
- [43] Neutrophil-to-Lymphocyte Ratio Predicts Restenosis After Drug-Coated Balloon Therapy for Femoropopliteal Artery Lesions: A Retrospective Study FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
- [47] Plain uncoated balloon versus drug-coated balloon in the management of in-stent restenosis of femoropopliteal lesions: a comparative study of the effect of lesion length on the outcome EGYPTIAN JOURNAL OF SURGERY, 2022, 41 (01): : 231 - 238
- [48] The LEVANT I (Lutonix Paclitaxel-Coated Balloon for the Prevention of Femoropopliteal Restenosis) Trial for Femoropopliteal Revascularization First-in-Human Randomized Trial of Low-Dose Drug-Coated Balloon Versus Uncoated Balloon Angioplasty JACC-CARDIOVASCULAR INTERVENTIONS, 2014, 7 (01) : 11 - 19